Tianye Li
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
From M7824 to SHR-1701: lessons for dual PD-L1/TGF-β targeting.
Journal: Journal for immunotherapy of cancer
Published: June 08, 2026
Advances in the clinical application of bispecific antibodies in cancer therapy.
Journal: iScience
Published: January 01, 2026
An asymptomatic postmenopausal uterine perforation with bilateral embedment by a V-shaped intrauterine device: a case report.
Journal: Frontiers in medicine
Published: December 21, 2025
Immunotherapy in endometrial cancer: mechanisms, clinical evidence, and future directions.
Journal: Frontiers in immunology
Published: September 01, 2025
Development and application of antibody-drug conjugates in gynecological cancers.
Journal: Science China. Life sciences
Published: January 26, 2025
Tailoring traditional Chinese medicine in cancer therapy.
Journal: Molecular cancer
Published: October 07, 2024
Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021.
Journal: Journal of hematology & oncology
Published: September 07, 2024
Blockade of CCR5+ T Cell Accumulation in the Tumor Microenvironment Optimizes Anti-TGF-β/PD-L1 Bispecific Antibody.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 25, 2024
Harnessing the evolving CRISPR/Cas9 for precision oncology.
Journal: Journal of translational medicine
Published: April 30, 2024
Targeting cytokine and chemokine signaling pathways for cancer therapy.
Journal: Signal transduction and targeted therapy
Published: February 28, 2024
The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling.
Journal: Cell communication and signaling : CCS
Published: December 29, 2023
Last Updated: 09/26/2026